Study of the Endovascular QUANTUM LP™ Stent Graft System in Abdominal Aortic Aneurysms (AAA)
Phase 3
Completed
- Conditions
- Abdominal Aortic Aneurysm
- Interventions
- Device: QUANTUM LP™ STENT GRAFT SYSTEMProcedure: Open surgical repair
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2009-05-01
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 300
- Registration Number
- NCT00233688
- Locations
- 🇺🇸
Newark Beth Israel Medical Center, Newark, New Jersey, United States
Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions
Phase 1
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: CYPHER Sirolimus-Eluting Coronary Stent
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2009-11-19
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 56
- Registration Number
- NCT00233714
- Locations
- 🇧🇷
Institute Dante Pazzanese of Cardiology, Sao Paolo, Brazil
Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)
Phase 4
Completed
- Conditions
- Pulmonary Embolism
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2008-08-05
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT00233740
The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.
Phase 2
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Bare metal Bx Velocity™Device: Sirolimus coated Bx Velocity™
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2008-08-06
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 220
- Registration Number
- NCT00233805
- Locations
- 🇫🇷
Dr Marie-Claude Morice, Massy, France
Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)
Phase 2
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2007-06-27
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 52
- Registration Number
- NCT00233779
- Locations
- 🇧🇷
Instituto Dante Pazzanese de Cardiologia, Sao Paolo, Brazil
Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)
Phase 1
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2008-04-24
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT00233766
- Locations
- 🇧🇷
Instituto Dante Pazzanese de Cardiologia, Sao Paolo, Brazil
FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent
Phase 1
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: sirolimus coated Bx VELOCITY stent - fast releaseDevice: sirolimus coated Bx VELOCITY stent - slow release
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2007-10-12
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 30
- Registration Number
- NCT00233792
- Locations
- 🇧🇷
Instituto Dante Pazzanese of Cardiology, Sao Paulo, Brazil
FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent
Phase 1
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Sirolimus-coated Bx VELOCITY Stent
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2007-10-12
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 15
- Registration Number
- NCT00233818
- Locations
- 🇳🇱
Erasmus Centrum Thoraxcentrum, Rotterdam, Netherlands
Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions
Phase 3
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: CYPHER Sirolimus-eluting Coronary Stent
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2010-03-16
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT00232739
- Locations
- 🇺🇸
Lenox Hill Hospital, New York, New York, United States
Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions
Phase 3
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: 4.0 CYPHER Sirolimus-Eluting Coronary Stent
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2009-12-02
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT00232752
- Locations
- 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath